Treatment of alopecia areata in children.
Mukherjee
Niyati
N
Department of Internal Medicine, University of North Carolina at Chapel Hill, NC 27599, USA. nmukherj@unch.unc.edu
Burkhart
Craig N
CN
Morrell
Dean S
DS
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000279:Administration, Cutaneous; D000506:Alopecia Areata / Q000628:therapy*; D000875:Anthralin / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003503:Cyclobutanes / Q000627:therapeutic use; D003521:Cyclopropanes / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D004137:Dinitrochlorobenzene / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D008914:Minoxidil / Q000627:therapeutic use; D010789:Phototherapy; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D003503:Cyclobutanes; D003521:Cyclopropanes; D003879:Dermatologic Agents; D004137:Dinitrochlorobenzene; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; C020637:squaric acid dibutyl ester; D008914:Minoxidil; C029402:diphenylcyclopropenone; D000875:Anthralin